Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000305414 | SCV000351005 | uncertain significance | Thrombophilia due to activated protein C resistance | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000305414 | SCV000351006 | uncertain significance | Thrombophilia due to activated protein C resistance | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000342069 | SCV000351007 | uncertain significance | Factor V deficiency | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000398267 | SCV000351008 | uncertain significance | Thrombophilia due to thrombin defect | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000307080 | SCV000351009 | uncertain significance | Budd-Chiari syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV003761905 | SCV001120383 | benign | Congenital factor V deficiency | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000342069 | SCV001456808 | benign | Factor V deficiency | 2020-09-16 | no assertion criteria provided | clinical testing |